Back
Autodesk, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
58
ADSK
Autodesk, Inc.
Last Price:
$293.99
Seasonality Move:
2.72%
Buy
82
KYMR
Kymera Therapeutics, Inc.
Last Price:
$84.15
Seasonality Move:
10.35%
Buy
58
Autodesk, Inc. (ADSK)
is a Buy
Is Autodesk, Inc. a Buy, Sell or Hold?
-
The current Autodesk, Inc. [ADSK] share price is $294.31. The Score for ADSK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ADSK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $85.68. The Score for KYMR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ADSK Stock Price Chart
What is Autodesk, Inc.'s stock price today?
-
The Autodesk, Inc. share price today is $294.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADSK is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $85.68The current trend is moderately bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
ADSK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.65 | Sell |
| Relative Strength Index (14 RSI): | 41.07 | Sell |
| Chaikin Money Flow: | -1312428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (292.87 - 304.83) | Sell |
| Bollinger Bands (100): | (292.54 - 317.16) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.03 | Buy |
| Relative Strength Index (14 RSI): | 65.78 | Buy |
| Chaikin Money Flow: | -694626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.5 - 81.28) | Buy |
| Bollinger Bands (100): | (43.11 - 67.75) | Buy |
ADSK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 300.96 | Sell |
| 20-day SMA: | 298.62 | Sell |
| 50-day SMA: | 302.56 | Sell |
| 200-day SMA: | 293.43 | Buy |
| 8-day EMA: | 299.5 | Sell |
| 20-day EMA: | 300.26 | Sell |
| 50-day EMA: | 302.23 | Sell |
| 200-day EMA: | 296.55 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.39 | Buy |
| 20-day SMA: | 72.77 | Buy |
| 50-day SMA: | 65.1 | Buy |
| 200-day SMA: | 45.62 | Buy |
| 8-day EMA: | 83.4 | Buy |
| 20-day EMA: | 75.58 | Buy |
| 50-day EMA: | 66.65 | Buy |
| 200-day EMA: | 51.3 | Buy |
Autodesk, Inc. Earnings Growth & ADSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.07 per share, an increase this year of $0.84 per share, and an increase next year of $1.91 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.30 per share.
Autodesk, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||